What's next for Boston Scientific after Farapulse's FDA approval?
Chief Medical Officer Dr. Ken Stein explains the plans at Boston Scientific after its landmark pulsed field ablation approval
Stay updated with breaking news from Ken Stein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Chief Medical Officer Dr. Ken Stein explains the plans at Boston Scientific after its landmark pulsed field ablation approval
Boston Scientific Corporation (NYSE:BSX) Q3 2023 Earnings Call Transcript October 26, 2023 Boston Scientific Corporation beats earnings expectations. Reported EPS is $0.5, expectations were $0.48. Operator: Good day, and welcome to the Boston Scientific Third Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be […]
Operator: Good day, and welcome to the Boston Scientific Third Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode.
The Israel Scholar-in-Residence Weekend with Ken Stein will be held from Oct. 20 to Oct. 22 at B’nai Jeshurun Congregation at 27501 Fairmount Blvd. in Pepper Pike. The program will
To commemorate the 50th anniversary of Israel’s 1973 Yom Kippur War, B’nai Jeshurun Congregation in Pepper Pike opened an exhibit Sept. 25, and held an event Sept. 27 to learn,